Virtu Financial LLC Transcode Therapeutics, Inc. Transaction History

Virtu Financial LLC

  • $1.43 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 15, 2023
BUY
$0.33 - $984.0 $5,399 - $16.1 Million
16,361 New
16,361 $11,000
Q4 2021

Feb 17, 2022
SELL
$2.42 - $3.41 $43,714 - $61,598
-18,064 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$2.37 - $6.45 $42,811 - $116,512
18,064 New
18,064 $54,000

Others Institutions Holding RNAZ

# of Institutions
1
Shares Held
6.5K
Call Options Held
0
Put Options Held
0
View Full List

About Transcode Therapeutics, Inc.

RNAZ Quotes by TradingView
  • Ticker RNAZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,977,200
  • Market Cap $4.8M
  • Description
  • TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. The company's products in preclinical programs incl...
More about RNAZ
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email